Brainsway Ltd.
Brainsway Ltd. is listed today as BrainsWay Ltd.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2024 | $20 M | Private placement after listing | $10 to $50 million | equity, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Brainsway Ltd. chose not to state its revenue in its newest notice of a funding round (Oct 2024).
SEC Form D · Oct 2024
The industry group it chose in its notices: Biotechnology.
SEC Form D · Oct 2024
That is all the official record says: Brainsway Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Brainsway Ltd. are on record.
Investors#
No investor of Brainsway Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding BrainsWay Ltd. shares, as of Sep 30, 2026.
- Valor Management LLC$70 M13.45%
- Masters Capital Management LLC$16 M3.15%
- Acadian Asset Management LLC$10 M1.95%
- Essex Investment Management Co LLC$8 M1.46%
- Renaissance Technologies LLC$6 M1.13%
- Cresset Asset Management, LLC$4 M0.80%
- HWG Holdings LP$3 M0.64%
- Morgan Stanley$3 M0.63%
- Y.D. More Investments Ltd$3 M0.57%
- Eagle Global Advisors LLC$2 M0.46%
- Legato Capital Management LLC$2 M0.45%
- ARK Investment Management LLC$2 M0.37%
- Jpmorgan Chase & Co$2 M0.32%
- SEI Investments Co$2 M0.30%
- Walleye Capital LLC$1 M0.27%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Hadar Levy | Chief Executive Officer | Oct 2024 |
| Ido Marom | Chief Financial Officer | Oct 2024 |
| Abraham Zangen | Director | Oct 2024 |
| Ami Boehm | Chairman of the Board of Directors | Oct 2024 |
| Avner Hagai | Director | Oct 2024 |
| Avner Lushi | Director | Oct 2024 |
| David Zacut | Vice Chairman of the Board of Directors | Oct 2024 |
| Eti Mitrany | Director | Oct 2024 |
| Karen Sarid | Director | Oct 2024 |
| Yossi Ben Shalom | Director | Oct 2024 |
About
Medical technology company.
Went public since 2019. Its SEC number is that of a company listed on a stock exchange.